ArticleEuropean radiology2024
Value of [
Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 21 citations in OpenAlex.
- Distinguishing Organizing Pneumonia from Malignancy During Cancer Surveillance: Predominant Diagnostic Value of Imaging over Systemic Inflammatory Biomarkers.Current oncology (Toronto, Ont.) · 2026Article
- Discordant [European journal of nuclear medicine and molecular imaging · 2026Article
- Observational
- Value of [European journal of nuclear medicine and molecular imaging · 2026Article
- Case Report: Coexistence of a giant borderline phyllodes tumor of the breast and a contralateral fibroadenoma: a challenging case with clinical manifestations and PET-CT imaging mimicking advanced cancer.Frontiers in oncology · 2026Article
- Diagnostic value of [Frontiers in oncology · 2026Article
- Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review.EJNMMI reports · 2025Review
- Insights into lung cancer diagnosis and clinical management using [Annals of nuclear medicine · 2025Article
- Evaluating the diagnostic value ofJapanese journal of radiology · 2025Article
- Added value of dual-phaseFrontiers in oncology · 2025Article
- Review
- Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET).Npj imaging · 2024Review
- [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial.Pharmaceuticals (Basel, Switzerland) · 2024Article
- The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2024Review
- The impact of FAP imaging in lung cancer and beyond: a new chapter.European radiology · 2024Article
- Comparative analysis of two timepoints on [European journal of hybrid imaging · 2023Article
- [Respiratory research · 2023Article
- Mapping knowledge structure and themes trends of cancer-associated fibroblasts: a text-mining study.Frontiers in molecular biosciences · 2023Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
objectiveUptake of the imaging tracers [
methodsWe retrospectively analyzed [
resultsA total of 70 inflammatory and 37 malignant lung lesions were evaluated by [
conclusion[ CLINICAL RELEVANCE STATEMENT: Our study confirmed that the uptake of [ KEY POINTS: • Malignant and different inflammatory lung lesions showed varying degrees of uptake of [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.